Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 5hid | B1E | Serine/threonine-protein kinase B-raf | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 5hid | B1E | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 1.000 | |
| 4h1m | 0YJ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.534 | |
| 5hi2 | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.522 | |
| 1wbs | LI2 | Mitogen-activated protein kinase 14 | / | 0.509 | |
| 1kv2 | B96 | Mitogen-activated protein kinase 14 | / | 0.502 | |
| 2e2b | 406 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.502 | |
| 3gcu | R48 | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 3gcv | SS6 | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 3hv6 | R39 | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 3o8u | BMU | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 3uvr | 06F | Mitogen-activated protein kinase 14 | / | 0.483 | |
| 3vhe | 42Q | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.482 | |
| 1kv1 | BMU | Mitogen-activated protein kinase 14 | / | 0.481 | |
| 3p7b | P7B | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 3p7c | P7C | Mitogen-activated protein kinase 14 | / | 0.474 | |
| 3wze | BAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.472 | |
| 3nnu | EDB | Mitogen-activated protein kinase 14 | / | 0.467 | |
| 2b00 | GCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.464 | |
| 4hw7 | 64M | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.463 | |
| 3d83 | GK6 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 2hzn | KIN | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.460 | |
| 4r7i | STI | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.460 | |
| 1wbn | L09 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 2hiw | 7MP | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.459 | |
| 2yis | YIS | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 3hv4 | L51 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4asd | BAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.459 | |
| 5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.458 | |
| 2cke | IQU | Death-associated protein kinase 2 | / | 0.454 | |
| 3cs9 | NIL | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.454 | |
| 3nnw | EDD | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.453 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.453 | |
| 3qw2 | NAD | Myo-inositol-1-phosphate synthase (Ino1) | / | 0.452 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.450 | |
| 4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 3mv5 | XFE | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.448 | |
| 4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.448 | |
| 2j5x | GSP | ADP-ribosylation factor 6 | / | 0.447 | |
| 3e93 | 19B | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 3p7a | P7A | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
| 1wbt | WBT | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 4dta | ADN | APH(2'')-Id | / | 0.442 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
| 1rdw | LAR | Actin, alpha skeletal muscle | / | 0.441 | |
| 1tez | FAD | Deoxyribodipyrimidine photo-lyase | 4.1.99.3 | 0.440 | |
| 3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.440 |